Medication Augmentation for OCD with Amitriptyline and Modafinil
For a patient already on amitriptyline (TCA) and modafinil who needs additional medication for OCD symptoms, an SSRI such as sertraline should be added as first-line treatment, with careful monitoring for serotonin syndrome due to the combination with amitriptyline. 1
First-Line Augmentation Options
SSRI Addition
- SSRIs are the first-line pharmacological treatment for OCD according to the American College of Physicians and American Psychiatric Association 1
- Sertraline is extensively studied at higher doses for OCD (50-200 mg/day) and would be the preferred SSRI option 1
- Fluoxetine (20-60 mg/day) is another well-established option 1
- Fluvoxamine has demonstrated efficacy but may have more side effects than sertraline 1
Important Cautions
- When adding an SSRI to amitriptyline, there is significant risk of serotonin syndrome and increased blood levels of both medications 2
- Start with lower doses than usual and titrate slowly while monitoring for signs of serotonergic toxicity
- Consider reducing amitriptyline dose when adding the SSRI
- Clinical improvement typically begins by week 6, with maximal improvement by week 12 1
Second-Line Augmentation Options
If SSRI addition is ineffective or not tolerated, consider:
Antipsychotic Augmentation
- Risperidone or aripiprazole have the strongest evidence for OCD augmentation 2, 1
- Only about one-third of patients with SSRI-resistant OCD show clinically meaningful response to antipsychotic augmentation 2
- Requires careful monitoring for metabolic side effects and weight gain
Glutamatergic Agents
- N-acetylcysteine has the largest evidence base as a glutamatergic augmentation agent (three out of five randomized controlled trials showed superiority to placebo) 2, 1
- Memantine has demonstrated efficacy in several trials for treatment-resistant OCD 2, 1
- Other options include lamotrigine, topiramate, and riluzole 2, 1
Treatment Algorithm
- First step: Add sertraline starting at 25-50 mg/day, gradually increasing to 50-200 mg/day over 4-6 weeks
- If partial response after 12 weeks: Increase to maximum tolerated dose
- If inadequate response after 12 weeks at maximum dose:
- Option A: Switch to a different SSRI (fluoxetine or fluvoxamine)
- Option B: Add N-acetylcysteine (most evidence-based glutamatergic agent)
- Option C: Add risperidone or aripiprazole (start with low doses)
- If still inadequate response: Consider memantine augmentation
Monitoring and Side Effects
- Monitor closely for signs of serotonin syndrome (confusion, agitation, muscle rigidity, hyperthermia)
- Watch for suicidal ideation, especially in the first months and after dose adjustments 1
- Be alert for behavioral activation/agitation, which is more common in anxiety disorders 1
- Assess for drug interactions between all three medications (amitriptyline, modafinil, and the added agent)
Non-Pharmacological Considerations
- Consider adding cognitive-behavioral therapy with exposure and response prevention (CBT-ERP), which has larger effect sizes than pharmacological therapy alone 1
- For very treatment-resistant cases, neuromodulation approaches like deep repetitive TMS or rTMS targeting the supplementary motor cortex or dorsolateral prefrontal cortex may be considered 2, 1
Common Pitfalls to Avoid
- Inadequate dosing of the SSRI (OCD often requires higher doses than depression)
- Premature discontinuation before full effect is achieved (minimum 12 weeks)
- Failure to recognize partial response
- Insufficient monitoring for serotonin syndrome with the amitriptyline-SSRI combination